Creative Planning Abeona Therapeutics Inc. Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$3.17 - $8.05 $15,729 - $39,944	-4,962 Reduced 33.07%	10,043 $42,000
Q1 2024 May 10, 2024	BUY	$4.07 - $8.68 $61,070 - $130,243	15,005 New	15,005 $108,000
Q3 2023 Nov 16, 2023	BUY	$2.98 - $4.43 $41,734 - $62,042	14,005 New	14,005 $58,000
Q1 2023 May 15, 2023	BUY	$2.25 - $3.27 $4,500 - $6,540	2,000 Added 9.99%	22,011 $62,000
Q4 2022 Feb 10, 2023	BUY	$2.4 - $5.65 $48,026 - $113,062	20,011 New	20,011 $61,000

26.9M

614K

45K

Ticker ABEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,950,380
Market Cap $33.9M
Description
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.